Immediate Impact

1 by Nobel laureates 4 from Science/Nature 53 standout
Sub-graph 1 of 22

Citing Papers

Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
Transition-Metal-Based Nanozymes: Synthesis, Mechanisms of Therapeutic Action, and Applications in Cancer Treatment
2024 Standout
2 intermediate papers

Works of Eva‐Lotte Lindstedt being referenced

Design of FLAIR: a Phase 2b Study of the 5-Lipoxygenase Activating Protein Inhibitor AZD5718 in Patients With Proteinuric CKD
2021
Myeloperoxidase is a potential molecular imaging and therapeutic target for the identification and stabilization of high-risk atherosclerotic plaque
2018

Author Peers

Author Last Decade Papers Cites
Eva‐Lotte Lindstedt 106 96 133 314 128 19 626
Kyo Won Seo 49 76 138 261 128 23 642
En‐Hui Yao 86 160 75 326 110 18 621
P. V. Halushka 178 106 134 189 125 27 668
K. Rühling 99 102 132 149 174 20 620
Sujie Jia 39 96 142 257 165 32 686
Ruolan Dong 60 48 75 260 75 28 656
Jack Wong 83 60 111 315 242 9 730
Jiangyang Chi 89 121 80 407 117 20 712
Elena Nobili 57 119 72 188 74 16 552
Hu Xu 53 109 57 234 85 38 641

All Works

Loading papers...

Rankless by CCL
2026